Keyphrases
Adrenocortical Carcinoma
80%
Advanced Adrenocortical Carcinoma
100%
Antiresorptive
20%
Antisecretory Medication
20%
Bisphosphonates
40%
Bone Fracture
20%
Bone Metastasis
100%
Clinical Characteristics
20%
Confidence Interval
20%
Cortisol
40%
Denosumab
40%
European Countries
20%
France
20%
Hazard Ratio
20%
Hazard Risk
20%
High Mortality
20%
High Risk
20%
Hypercalcemia
20%
Hypersecretion
40%
Italy
20%
Liver
20%
Low Risk
20%
Lung
20%
Lymph Node
20%
Median Overall Survival
20%
Mitotane
20%
Mortality Risk
20%
Multicenter Retrospective Study
100%
Multivariate Analysis
20%
Netherlands
20%
One-center
20%
Patient Outcomes
20%
Poor Prognosis
20%
Potential Gains
20%
Prognostic Factors
60%
Prospective Clinical Trial
20%
Rare Cancer
20%
Risk of Death
20%
Skeletal-related Events
100%
Spinal Cord Compression
20%
Survival Benefit
20%
Therapeutic Range
20%
Therapeutic Role
20%
United States
20%
INIS
administration
14%
bone fractures
14%
bones
100%
cancer
14%
carcinomas
100%
clinical trials
14%
compression
14%
cortisol
28%
data
14%
death
14%
france
14%
hazards
14%
italy
14%
levels
14%
liver
14%
lungs
14%
lymph nodes
14%
metastases
100%
morbidity
100%
mortality
100%
multivariate analysis
14%
netherlands
14%
patients
100%
range
14%
risks
42%
spinal cord
14%
therapy
14%
usa
14%
Medicine and Dentistry
Adrenal Cortex Carcinoma
100%
Bisphosphonate
40%
Bone Metastasis
100%
Clinical Trial
20%
Denosumab
40%
Drug Therapy
20%
Fracture
20%
Hazard Ratio
20%
Hydrocortisone
40%
Hypercalcaemia
20%
Lung
20%
Lymph Node
20%
Malignant Neoplasm
20%
Mitotane
20%
Multivariate Analysis
20%
Overall Survival
20%
Prognostic Factor
60%
Retrospective Study
100%
Spinal Cord Compression
20%
Pharmacology, Toxicology and Pharmaceutical Science
Adrenal Cortex Carcinoma
100%
Bisphosphonic Acid Derivative
40%
Bone Metastasis
100%
Clinical Trial
20%
Denosumab
40%
Fracture
20%
Hydrocortisone
40%
Hypercalcaemia
20%
Malignant Neoplasm
20%
Mitotane
20%
Overall Survival
20%
Retrospective Study
100%
Spinal Cord Compression
20%